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Secretory proteins unable to assemble into
their native states in the endoplasmic reticulum
(ER) are transported back or ‘‘retrotranslo-
cated’’ into the cytosol for ER-associated
degradation (ERAD). To examine the roles of dif-
ferent components in ERAD, one fluorescence-
labeled ERAD substrate was encapsulated
with selected lumenal factors inside mammalian
microsomes. After mixing microsomes with
fluorescence-quenching agents and selected
cytosolic proteins, the rate of substrate efflux
was monitored continuously in real time by the
decrease in fluorescence intensity as cytosolic
quenchers contacted dye-labeled substrates.
The retrotranslocation kinetics of nonglycosy-
lated pro-a factor were not significantly altered
by replacing all lumenal proteins with only pro-
tein disulfide isomerase or all cytosolic proteins
with only PA700, the 19S regulatory particle of
the 26S proteasome. Retrotranslocation was
blocked by antibodies against a putative retro-
translocation channel protein, derlin-1, but not
Sec61a. In addition, pro-a factor photocros-
slinked derlin-1, but not Sec61a. Thus, derlin-1
appears to be involved in pro-a factor retro-
translocation.
INTRODUCTION
In eukaryotic cells, most secreted proteins are translo-
cated cotranslationally into the lumen of the endoplasmicreticulum (ER), where they are glycosylated, fold, form di-
sulfide bonds, and assemble into native structures before
being transported to various destinations (Johnson and
van Waes, 1999; Fewell et al., 2001; Ellgaard and Helen-
ius, 2003; Trombetta and Parodi, 2003). When a polypep-
tide is unable to reach a native conformation, it is usually
directed into the ER-associated degradation (ERAD) path-
way (Tsai et al., 2002; McCracken and Brodsky, 2003;
Kostova and Wolf, 2003; Ro¨misch, 2005; Meusser et al.,
2005). Since most proteases that degrade misfolded or
misassembled proteins are located in the cytosol, ERAD
substrates must be transported back through the ER
membrane into the cytosol for degradation. This pro-
cess—the movement of polypeptides from the ER lumen
to the cytosol—has been termed retrotranslocation or
dislocation.
Retrotranslocation is an intrinsically complex process:
the ERAD quality-control machinery must distinguish mis-
folded proteins in the ER lumen from proteins that are on
the way to folding properly, and ERAD substrates must
be targeted to a retrotranslocation site in the ER mem-
brane, transported through the membrane, and directed
to sites of proteolysis (Johnson and Haigh, 2000). Proteins
in and on both sides of the ER membrane are therefore
required to function together to accomplish this mecha-
nistically difficult task. Since ERAD was first identified
(Sommer and Jentsch, 1993; Ward et al., 1995; Jensen
et al., 1995; McCracken and Brodsky, 1996; Hiller et al.,
1996; Hampton et al., 1996), a number of proteins have
been shown to be involved directly or indirectly in retro-
translocation. While the specific roles of some proteins
have been determined, the functions of others are either
unknown or controversial.
The confusing and sometimes contradictory data about
the involvement of specific proteins in retrotranslocation
result in part from limitations in the experimentalCell 129, 943–955, June 1, 2007 ª2007 Elsevier Inc. 943
approaches currently available to examine this process,
especially in mammalian systems. First, in most in vivo
and in vitro studies, ERAD substrates are synthesized in
the cytoplasm and cotranslationally translocated into the
ER lumen concurrent with ongoing retrotranslocation
and degradation. Thus, approaches to study retrotranslo-
cation are complicated by the inability to discriminate
between substrates on their way into the ER lumen and
those on their way out. Even the presence of a lumen- or
cytosol-specific covalent modification (e.g., signal se-
quence cleavage, glycosylation, or ubiquitinylation) can-
not distinguish between proteins that have been com-
pletely translocated and those that were trapped at
some stage prior to complete translocation. These reali-
ties interfere with accurate quantification of the extent of
retrotranslocation. Second, the kinetics of retrotransloca-
tion are difficult to quantify accurately, both for the above
reasons and because retrotranslocation cannot be syn-
chronized in most experiments. Since translocation and
retrotranslocation proceed simultaneously both in vivo
and in vitro at unknown and perhaps variable rates, there
is currently no way to prepare samples in which all sub-
strates are in the same state at a specific time. Hence,
synchronous initiation of retrotranslocation for all sub-
strates in a sample has been impossible. Third, the role
of a particular protein in retrotranslocation is difficult to as-
certain inmany approaches. For example, the knockout of
a particular gene may alter in vivo retrotranslocation activ-
ity, but it is difficult to know whether the observed change
in activity is a primary or secondary effect. Interpretations
are further complicated if the loss of a specific protein is
obscured by the presence of another protein that is par-
tially or wholly redundant.
To overcome these limitations, we developed a mam-
malian in vitro system that allows monitoring of retrotrans-
location synchronously and in real time in the absence
of concurrent translocation. A purified full-length and
fluorescence-labeled ERAD substrate is encapsulated
into mammalian ER microsomes with a selection of puri-
fied lumenal proteins (none, one, two, or all). Upon mixing
the resulting vesicles with the desired purified cytosolic
proteins, a well-defined and homogeneous sample is cre-
ated. The movement of substrates from the lumen to the
cytosol is then detected spectroscopically to provide
a continuous real-timemeasurement of the retrotransloca-
tion rate. Using this biophysical approach, we report here
on the individual molecular species in the cytosol, ER
membrane, and lumen that are required for the retrotrans-
location of one ERAD substrate from the mammalian ER.
RESULTS
Experimental Design
Fluorescence-labeled ERAD substrate molecules and a
known selection of lumenal components are encapsu-
lated inside ER microsomes. When such microsomes
are added to a solution containing a known selection of
cytosolic components, the resultant sample is well de-944 Cell 129, 943–955, June 1, 2007 ª2007 Elsevier Inc.fined biochemically, with the desired molecular species
on each side of the ER membrane. The retrotranslocation
of fluorescence-labeled substrates from the lumenal to the
cytosolic side of the membrane is detected because the
cytosol also contains fluorescence-quenching agents.
The rate of substrate retrotranslocation is therefore moni-
tored directly in real time by the reduction in sample emis-
sion intensity as the dyes covalently attached to the sub-
strate move through the ER membrane and are exposed
to the quenchers. Since all substratemolecules are initially
encapsulated insidemicrosomes and retrotranslocation is
initiated by increasing the temperature, substrate retro-
translocation is synchronized and reproducible. More-
over, by varying the lumenal and cytosolic components
in parallel samples, the requirement for individual factors
during retrotranslocation may be revealed by even subtle
changes in the kinetics of substrate retrotranslocation.
The ERAD substrate used in this study was Dgpaf,
a nonglycosylated derivative of the yeast pro-a factormat-
ing pheromone. Because both yeast (Caplan et al., 1991;
McCracken and Brodsky, 1996) and mammals (Su et al.,
1993) recognize and degrade Dgpaf, it is a legitimate
model ERAD substrate. Furthermore, Dgpaf is soluble;
is not ubiquitinylated; and lacks disulfide bonds, carbo-
hydrates, and transmembrane sequences. Since these
structural features may complicate retrotranslocation
and require additional or different mechanisms and/or
components, in this initial study we chose Dgpaf to estab-
lish the minimal requirements for retrotranslocation.
Retrotranslocation of Fluorescence-
Labeled Substrate
Todeterminewhether thecovalent attachmentofafluores-
cent dye to Dgpaf would interfere with retrotranslocation,
we incorporated BODIPY FL (BOF) dyes into the prepro
substrate, pDgpaf, by adding N3-(4,4-difluoro-5,7-
dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionyl)-Lys-
tRNALys (3BOF-Lys-tRNALys; Woolhead et al., 2004) to an
in vitro translation system. Most, but not all, of the pDgpaf
translocated into the lumen was converted to Dgpaf by
signal peptidase. The efficiency of conversionwascompa-
rable to that observed in reactions employing pDgpaf and
yeast microsomes (McCracken and Brodsky, 1996; Pilon
et al., 1997). After purification by sedimentation, themicro-
somes were added to rabbit reticulocyte lysate that con-
tained ATP and lacked mRNA, whereupon Dgpaf exit
from the microsomes was monitored (Figure 1A). The
amount of radiolabeled (lanes 1–12) and BOF-labeled
(lanes 1–9) Dgpaf in microsomes decreased markedly
over time in samples with either complete lysate (lanes
1–3) or lysate lacking hemoglobin (lanes 4–6 and 10–12),
but not in samples lacking cytosol (lanes 7–9). Cytosolic
proteins were therefore required for retrotranslocation.
The time-dependent decrease in total Dgpaf showed
that the retrotranslocated Dgpaf was degraded, primarily
by the proteasome because degradation was inhibited
by lactacystin (see Figure S1A in the Supplemental Data
available with this article online). The rates of degradation
Figure 1. Retrotranslocation and Degra-
dation of Dgpaf-BOF
After pDgpafmRNAwas translated in vitro in the
presence of [35S]Met, SRP, microsomes, and
either 3BOF-Lys-tRNALys (lanes 1–9) or Lys-
tRNALys (lanes 10–12), the microsomes were
pelleted and then added to solutions containing
ATPandeither reticulocyte lysate (cytosol, lanes
1–3), lysate lacking hemoglobin (cytosol-Hb,
lanes 4–6 and 10–12), or no lysate (no cytosol,
lanes 7–9). The average percentages of Dgpaf-
BOF radioactivity (A) and BOF emission (B)
remaining at 15 and 30 min (0 min = 100%) for
each sample are shown. (n = 7; ±3%–7% for
35S, ±2%–6% for BOF.) *, Dgpaf-BOF; **,
pDgpaf-BOF.were similar for unlabeled Dgpaf and BOF-labeled Dgpaf
whether lysates lacked or contained hemoglobin (Fig-
ure 1A). Importantly, the same conclusions were reached
by monitoring BOF fluorescence rather than [35S]Met-
labeled protein: the amount of microsome-encapsulated
and BOF-labeled Dgpaf was reduced over time by incu-
bating the microsomes in lysate with or without hemo-
globin (Figure 1B, lanes 1–6), but little retrotranslocation
was detected in the absence of cytosol (Figure 1B, lanes
7–9). Therefore, the covalent attachment of BOF
to Dgpaf interfered with neither retrotranslocation nor
degradation.
Dgpaf-BOF and Microsomes with Defined
Lumenal Contents
One advantage of the spectroscopic approach is that sub-
strate from a single preparation of Dgpaf-BOF can be en-
capsulated and compared with parallel samples that have
different combinations of lumenal and/or cytosolic com-
ponents. This approach also eliminates substrate hetero-
geneity. We overexpressed and purified a recombinant
Dgpaf derivative with a C-terminal hexameric histidine
tag and four single-site mutations (N23Q, N57Q, and
N67Q to prevent glycosylation, and Y165C for dye attach-ment). Since no targeting to the translocon was required,
no signal sequence was present. This Dgpaf derivative
was then covalently modified with BOF and gel filtered
to remove unreacted dye, thereby yielding Dgpaf-BOF.
The lumenal contents of ERmicrosomeswere extracted
by exposure to pH 9.5–10.0 and separated from mem-
branes by sedimentation (Bulleid and Freedman, 1988;
Nicchitta and Blobel, 1993; Hamman et al., 1998; Haigh
and Johnson, 2002; Alder et al., 2005). After the mem-
branes were resuspended in a solution containing the
components to be encapsulated (e.g., Dgpaf-BOF, ATP,
and BiP), the solvent pH was reduced to 7.5 to reseal
the microsomes in their original orientation (lumen inside)
without any detectable loss of ribosome-binding activity.
Following gel filtration to separate the microsomes from
unencapsulated material, the reconstituted rough micro-
somes (RRMs) had a defined lumenal content.
To assess whether Dgpaf-BOF adsorbs to the outer
surface of RRMs, microsomes were subjected to mock
encapsulation procedures in the absence of Dgpaf-BOF
and then incubated with Dgpaf-BOF to allow adsorption.
After gel filtration, the BOF intensity of mock RRMs was
10% of that seen with RRMs that contained Dgpaf-
BOF. Since any cytosol-exposed Dgpaf-BOF wasCell 129, 943–955, June 1, 2007 ª2007 Elsevier Inc. 945
Figure 2. Fluorescence-Detected Retro-
translocation
(A) Reconstituted rough microsomes (RRMs;
gray) containing Dgpaf-BOF (cyan with yellow
dye), ATP, and a selection of lumenal proteins
(? = all, some, or none) are mixed on ice with
ATP, aBOF (anti-BOF antibodies; red), and
some selection of cytosolic proteins (? = all,
some, or none) (i). Retrotranslocation is initiated
at t0 by incubating samples at 30
C (ii). Retro-
translocation of Dgpaf-BOF from the inside to
the outside of the microsomes allows aBOF to
bind the BOF dye and quench its emission in-
tensity (iii). A direct real-time measure of the
rate and extent of Dgpaf-BOF retrotransloca-
tion is therefore given by the time-dependent
decrease in BOF intensity as more Dgpaf-BOF
molecules are exposed to aBOF (iv).
(B) The net emission intensities of samples with
and without aBOF were recorded as a function
of time and then normalized (F = F+aBOF/
FaBOF). F0 is the initial net normalized intensity
at t0, while F is the net normalized intensity at
any time t. The average F at each time point
for n separate experiments is plotted; error
bars in this and all other figures show the stan-
darderror of themean for eachpoint anddictate
line thickness. aBOF-dependent quenching is
shown for cptcyto (red, n = 48), ATP in the
absence of cytosolic proteins (black, n = 21),
and cyto lacking ATP (cyan, n = 7; 30 units/ml
apyrase was included in both the lumen and
the cytosol).
(C) CptRRMs were incubated for an extended
time with or without cytosol, and the net aBOF-dependent quenching (red, n = 3) was obtained by subtracting thecyto aBOF-dependent quenching
from the cptcyto aBOF-dependent quenching (Figure S2B). Thecyto quenching was also subtracted from itself to yield the expected flat line (black).
(D) CptRRMswere incubated (30C, 30min) with cptcyto (lane 2), no cyto (lane 3), or cptcyto inhibitedwith epoxomicin (lane 4); an equivalent amount of
RRMs was loaded directly into lane 1. After microsomes and encapsulated Dgpaf-BOF were removed by sedimentation, the amount of full-length
Dgpaf-BOF (d) in each supernatant was determined by SDS-PAGE and imager-detected BOF fluorescence.quenched before retrotranslocation was initiated (see
below), these molecules did not contribute to the spectral
changes shown below.
Fluorescence-Detected Retrotranslocation
In initial retrotranslocation experiments, microsomes con-
tained Dgpaf-BOF, ATP, and a full complement of lumenal
proteins that had been extracted, concentrated, and then
reconstituted back into RRMs (complete RRMs, or
‘‘cptRRMs’’). To obtain a full complement of cytosolic
proteins, rabbit reticulocyte lysate was first chromato-
graphed to remove hemoglobin because its presence in-
terfered with fluorescence measurements. The resulting
hemoglobin-free lysate, here termed ‘‘cyto,’’ was diluted
4-fold from the original lysate but still supported retro-
translocation (Figure 1A; Figure S1A) and was used in all
fluorescence experiments. A solution containing cyto
and ATP was designated complete cytosol, or ‘‘cptcyto.’’
The concentrations of ATP, cyto, and lumenal proteins
required for maximal retrotranslocation were determined
and used throughout this study. To detect substrate retro-
translocation, BOF-specific antibodies (aBOF) were
added to the cytosol. Since no retrotranslocation occurs946 Cell 129, 943–955, June 1, 2007 ª2007 Elsevier Inc.at 0C (Figure S3), RRMs were mixed with the cytosolic
components and aBOF on ice before retrotranslocation
was initiated by raising the temperature to 30C. Besides
allowing complete mixing, the 0C incubation allowed
aBOF to quench any residual nonencapsulated Dgpaf-
BOF before the reaction was initiated (t0).
Since aBOF binding to BOF strongly quenches its
emission, any retrotranslocation of lumenal Dgpaf-BOF
into the cytosol should result in a significant reduction in
sample emission intensity (Figure 2A). The magnitude of
the spectral change depends on the initial state of BOF
in the sample because BOF emission is partially quenched
in the full-length polypeptide, and proteolysis of Dgpaf-
BOF causes a 65% increase in BOF intensity (Supplemen-
tal Data). Therefore, to focus solely on aBOF-dependent
intensity changes, parallel samples with or without aBOF
were examined in each experiment. The magnitude of
the aBOF-dependent intensity change was then given
by the ratio of intensities with and without aBOF (F =
F+aBOF/FaBOF). Only the aBOF-dependent intensity is
shown here.
When cptRRMs were added to cptcyto, a substantial
aBOF-dependent decrease in BOF intensity was
observed (Figure 2B). Maximal aBOF-dependent quench-
ing averaged 46% ± 1% of the initial intensity after 2000 s.
Cytosol- and ATP-Dependent
Substrate Retrotranslocation
When cptRRMs were incubated in the absence of cyto-
solic proteins, the initial sample intensity was reduced
by 9% ± 1% after 2000 s (Figure 2B). Also, when apyrase,
an enzyme that hydrolyzes ATP, was included in both the
lumenal and cytosolic solutions, the rate and extent of
Dgpaf-BOF quenching were reduced by the same extent
(10% ± 3%; Figure 2B). Thus, both cytosolic proteins
and ATP are required for Dgpaf-BOF retrotranslocation,
as observed in yeast systems (McCracken and Brodsky,
1996; Pilon et al., 1997; Lee et al., 2004). However, the
fluorescence approach utilized heremeasures the kinetics
of ERAD substrate exposure to the cytosol continuously at
a time resolution higher than that achievable by other
methods.
The small, steady decrease in Dgpaf-BOF intensity ob-
served in the absence of either cytosol or ATP (Figure 2B)
was nearly identical to the decrease observed with
RRMs containing BODIPY-labeled glutathione, heavy-
chain binding protein (BiP), or protein disulfide isomerase
(PDI) (Figure S2A). Since BiP and PDI are ER-resident
proteins and are not retrotranslocation substrates, this
aBOF-dependent quenching appears to be unrelated to
retrotranslocation. Subtracting this background from the
observed signal change (Supplemental Data) yielded the
net retrotranslocation-dependent fluorescence change
(Figure 2C). Dgpaf-BOF retrotranslocation was complete
when the spectral change reached a plateau, which oc-
curred after 2000 s under our conditions.
Direct biochemical evidence for lumenal Dgpaf-BOF
transport into the cytosol was provided by incubating
cptRRMs with ATP and epoxomicin-treated cyto in the
absence of aBOF, removing the microsomes by sedimen-
tation, and quantifying the amount of Dgpaf-BOF fluores-
cence in the supernatant. On average (n = 3), 30% of full-
length Dgpaf-BOF was found in the supernatant under
these conditions (Figure 2D, lane 4). Much less Dgpaf-
BOF was found in the supernatant when proteasomes
were active (Figure 2D, lane 2), and none was found
when no retrotranslocation occurred (Figure 2D, lane 3).
PA700, the 19S Regulatory Particle of the 26S
Proteasome, Stimulates Dgpaf Retrotranslocation
The ATPase complex containing p97 (VCP; Cdc48 in
yeast), Ufd1, andNpl4 plays a critical role in the retrotrans-
location of several ERAD substrates (Bays and Hampton,
2002; Tsai et al., 2002; Carlson et al., 2006). To assess the
involvement of this complex in Dgpaf retrotranslocation,
cptRRMs were incubated with purified p97, Ufd1, Npl4,
and ATP. No increase in aBOF-dependent quenching
over background was observed (Figure 3A). The quench-
ing rate also did not change when excess p97 was added
to cptcyto (data not shown). Thus, Dgpaf retrotransloca-
tion is independent of p97 and its cofactors in this system.In yeast, 26S proteasomes stimulate Dgpaf retrotrans-
location (Lee et al., 2004) and possibly that of other
substrates (e.g., Mayer et al., 1998; Chillaro´n and Haas,
2000; Walter et al., 2001). When cptRRMs were incubated
with ATP and purified bovine 26S proteasomes, the max-
imal rates and extents of aBOF-dependent quenching
were nearly the same for pure 26S proteasomes and for
total cytosolic proteins (Figure 3B).
Figure 3. Retrotranslocation Dependence on Cytosolic Com-
ponents
(A–C) CptRRMswere incubated with ATP and the following: p97, Ufd1,
and Npl4 (red, n = 4), cyto (black), or no cyto (cyan) (A); 26S protea-
somes (red, n = 17), cyto (black), or no cyto (cyan) (B); and 19S RPs
(red, n = 10), NEM-treated 19SRPs (orange, n = 4), epoxomicin-treated
26S proteasomes (cyan, n = 4), no cyto (green), or cyto (black) (C). Net
aBOF-dependent spectral changes are shown after subtraction of
the –cyto background (cf. Figure 2C).
(D) Data in (C) shown on an expanded scale.Cell 129, 943–955, June 1, 2007 ª2007 Elsevier Inc. 947
To determine whether PA700 alone can promote
retrotranslocation, cptRRMs were incubated with ATP
and purified bovine PA700. Since an increase in aBOF-
dependent quenching was observed (Figure 3C), PA700
stimulated ATP-dependent Dgpaf retrotranslocation.
Moreover, the ATPase activity of PA700 was required be-
cause pretreating PA700 with NEM (DeMartino et al.,
1994) essentially blocked retrotranslocation (Figure 3C).
Continuous monitoring of Dgpaf-BOF intensity revealed
that the initial quenching rates were similar for samples
containing either purified 26S or purified 19S regulatory
particle (RP) (Figure 3D), but the total 19S-dependent
increase in quenching was much less than the total 26S-
dependent increase (Figure 3C).
The cause of the differential quenching between 26S-
and 19S-containing samples was revealed by incubating
cptRRMs with ATP and 26S that had been pretreated
with the proteasome inhibitors epoxomicin or lactacystin
(Gaczynska and Osmulski, 2005). The rates and extents
of aBOF-dependent quenching were nearly the same for
samples containing PA700 (Figure 3C), epoxomicin-
treated 26S (Figure 3C), lactacystin-treated 26S (data
not shown), or epoxomicin-treated cytosol (data not
shown). Hence, the 26S protease activity was responsible
for the different quenching profiles observed with 19S and
26S. This conclusion was confirmed by measuring the
BOF intensity of intact and proteolyzed Dgpaf-BOF and
its sensitivity to aBOF (Supplemental Data).
Since the spectral change observed in 26S-containing
samples includes contributions from both retrotransloca-
tion and degradation, the kinetics of retrotranslocation
are best quantified using spectral changes that are inde-
pendent of substrate digestion. Thus, the rate of Dgpaf-
BOF exposure to the cytosol under our conditions is
more accurately given by the t1/2 (the time required to
reach 50%of maximal quenching) in 19S-containing sam-
ples (2.2 min; Figure 3C) than by the t1/2 in 26S-containing
samples (8.3 min; Figure 3B). These data also reveal that
the maximal initial rate of Dgpaf-BOF retrotranslocation
can be achieved solely with ATP and PA700 (Figure 3D).
Only PDI Is Required for Maximal
Dgpaf Retrotranslocation
To determine whether lumenal proteins are essential for
Dgpaf-BOF retrotranslocation, RRMs were reconstituted
with Dgpaf-BOF, ATP, and various combinations of
lumenal proteins. When RRMs lacking all lumenal proteins
were compared with cptRRMs, the net aBOF-dependent
quenching was substantially reduced (Figure 4A). Thus,
lumenal proteins are required for maximal Dgpaf-BOF ret-
rotranslocation. However, some Dgpaf-BOF retrotranslo-
cation occurred at a slow rate even in the absence of
lumenal proteins.
To assess whether individual lumenal proteins stimulate
retrotranslocation, RRMs containing only BiP, ATP, and
Dgpaf-BOF in the lumen were incubated in cptcyto. BOF
quenching was higher with these RRMs than with RRMs
lacking all lumenal proteins (Figure 4A), which showed948 Cell 129, 943–955, June 1, 2007 ª2007 Elsevier Inc.that BiP stimulated Dgpaf-BOF retrotranslocation. How-
ever, the extent of BiP stimulation was much less than
that seen with a full complement of lumenal proteins and
was not increased by a higher BiP concentration. In con-
trast, when only PDI, ATP, and Dgpaf-BOF were reconsti-
tuted into RRMs, the maximal rate and extent of BOF
quenching were essentially equivalent to those obtained
with RRMs containing a full complement of lumenal
Figure 4. Retrotranslocation Dependence on Lumenal Com-
ponents
(A) RRMs containing Dgpaf-BOF and 2 mM ATP were reconstituted
with total lumenal proteins (black), no lumenal proteins (orange, n =
5), BiP (cyan, n = 4), or PDI (red, n = 7). Each RRM was then incubated
with cptcyto at 30C. For comparison, cptRRMs incubated in the ab-
sence of all cytosolic proteins are shown (green). Net aBOF-dependent
spectral changes are shown after subtraction of –cyto background (cf.
Figure 2C).
(B)Dgpaf-BOF (0.2 mM in buffer A) was titrated at 4Cwith oxidized PDI
(red, n = 6), reduced PDI (blue, n = 7), or purified BiP (black, n = 3). PDI
was reduced or oxidized by 30 min incubation at 30C in 5 mM DTT or
5mMGSSG, respectively; BiPwas incubatedwith 2mMATP for 10min
at 30C.
(C) RRMs containing Dgpaf-BOF and 2 mM ATP were reconstituted
with total lumenal proteins (black), no cytosolic proteins (green),
10 mM oxidized PDI + 5 mM GSSG (red, n = 3), or 10 mM reduced
PDI + 5 mM DTT (orange, n = 3). Data were analyzed as in (A).
proteins (Figure 4A). Thus, only PDI is required in the lu-
men for maximal Dgpaf-BOF retrotranslocation.
PDI Binds Directly to Dgpaf-BOF that Lacks Cys
PDI must stimulate retrotranslocation by interacting with
the ER membrane and/or the substrate. Free Dgpaf-BOF
was titrated with either reduced or oxidized PDI, and its
binding to Dgpaf-BOF was detected by an increase in
BOF anisotropy caused by the slower rotational rate of
PDIDgpaf-BOF than of Dgpaf-BOF. Both oxidized and
reduced PDI associated with Dgpaf (Figure 4B), but re-
duced PDI had a significantly higher affinity for this
ERAD substrate than oxidized PDI did (Kd values of 30
and 900 nM, respectively). Thus, PDI bound tightly to
Dgpaf-BOF even though it lacked disulfides and free thiols
(see below). In contrast, BiP did not detectably bind to
Dgpaf-BOF (Figure 4B).
Does the higher affinity of Dgpaf for reduced PDI than
for oxidized PDI affect the rate of retrotranslocation?
When Dgpaf-BOF was reconstituted into RRMs with
ATP and either oxidized or reduced PDI, the rate of retro-
translocation was significantly lower with reduced PDI
than with either oxidized (Figure 4C) or untreated (Fig-
ure 4A) PDI (PDI purified using our procedures is air
oxidized; N.J.B., unpublished data). Thus, although the
reduced form of PDI binds Dgpaf more tightly, maximal
retrotranslocation rates require oxidized PDI and/or oxida-
tion conditions in the lumen.
Derlin-1 Is Essential for Dgpaf Retrotranslocation
ERAD substrate transport from the lumen to the cytosol
was originally proposed to occur through the Sec61a
translocon pore, but more recent evidence has implicated
derlin-1 as a component of a retrotranslocation site (Lilley
and Ploegh, 2004; Ye et al., 2004; Schekman, 2004). We
therefore assessed the involvement of Sec61a and derlin
in Dgpaf-BOF retrotranslocation using both fluorescence
and photocrosslinking techniques.
We previously showed that affinity-purified antibodies
against Sec61a (aSec61a) blocked iodide ion passage
through the aqueous pores of ribosome-free translocons
(Hamman et al., 1998). It was therefore possible that
aSec61a could also inhibit Dgpaf-BOF retrotranslocation.
Yet preincubating cptRRMs with aSec61a altered neither
the rate nor the extent of Dgpaf-BOF quenching (Fig-
ure 5A).
The cytosolic end of the translocon pore can also be
blocked by the binding of a ribosome (Crowley et al.,
1994; Gillece et al., 2000; Schmitz et al., 2000). Although
this blockage is not stoichiometric (50% of RRM translo-
cons are bound under our conditions; Hamman et al.,
1998), one might expect a 50% reduction in potential ret-
rotranslocation channels to reduce the maximal rate of
retrotranslocation. Ribosome-nascent chain complexes
(RNCs) with an 86-residue preprolactin nascent chain
were purified and then incubated with cptRRMs and
SRP to target the RNCs to Sec61a translocons. The re-
sulting RRMs were incubated with cptcyto to initiateFigure 5. Retrotranslocation Dependence on Membrane
Components
(A and B) CptRRMs (10 Eq) were preincubated with 3 mg/ml aSec61a
(red, n = 3) (A) or 10–20 nM RNCs, 40 nM SRP, and 1 mMGTP (red, n =
2) (B) before the addition of cptcyto and incubation at 30C. Also in (B),
RRMs containing 20 mM T37G BiP mutant and 2 mM ATP were incu-
bated in cptcyto (cyan, n = 5).
(C) CptRRMs were preincubated with 3 mg/ml aDer1 (red, n = 6; cyan,
n = 3) or aSec61a (orange, n = 4) before the addition of cptcyto (red)
or 20 mg/ml 26S proteasomes (cyan, orange) and incubation at
30C. For comparison, cptRRMs incubated in the presence ([A] and
[B] = black; [C] = green) or absence ([A] and [B] = green; [C] = black)
of all cytosolic proteins are shown in (A)–(C). The aBOF-dependent
quenching is shown after subtraction of –cyto background (cf.
Figure 2C).
(D) Data in (C) shown on an expanded scale.Cell 129, 943–955, June 1, 2007 ª2007 Elsevier Inc. 949
retrotranslocation, and the rate of Dgpaf retrotransloca-
tion was not affected by the tight binding of RNCs to trans-
locons (Figure 5B).
The lumenal end of the aqueous translocon pore can be
closed by BiP, either directly or indirectly (Hamman et al.,
1998; Haigh and Johnson, 2002; Alder et al., 2005).
Whereas BiP-mediated closure is regulated and reversible
under normal conditions, the pores in ribosome-free
translocons are closed irreversibly if RRMs are prepared
with ATP and a T37G BiP mutant in which communication
between the nucleotide and peptide-binding domains is
defective (Alder et al., 2005). When RRMs containing
T37G BiP, ATP, and Dgpaf-BOF were incubated with
cptcyto, the rate and extent of aBOF-dependent quench-
ing did not differ significantly from samples containing
wild-type BiP (Figure 5B). These data strongly suggest
that Dgpaf-BOF does not pass through the translocon
pore during retrotranslocation.
In contrast, when cptRRMs were preincubated
with aDer1 (affinity-purified antibodies that bind to the C-
terminal region of derlin-1), aBOF-dependent quenching,
and hence Dgpaf-BOF retrotranslocation, was reduced
by more than 80% (Figure 5C). aDer1, but not aSec61a,
also blocked 26S stimulation of retrotranslocation
(Figure 5C). Yet the aDer1 effect was more complex than
simple blockage: even after RRMs were incubated with
an excess of aDer1 at 0C, the rate of aBOF-dependent
quenching was initially unaltered (Figure 5D). But after
2 min at 30C, Dgpaf-BOF retrotranslocation was totally
blocked. Thus, aDer1 can block the retrotranslocation
machinery, but only after a short lag.
Dgpaf Photocrosslinks Derlin-1
To determine which molecules are adjacent to Dgpaf
during retrotranslocation, photoreactive probes were
incorporated into pDgpaf in an in vitro translation contain-
ing N3-(5-azido-2-nitrobenzoyl)-Lys-tRNALys (3ANB-Lys-
tRNALys; Krieg et al., 1986). After microsomes were
pelleted and resuspended in cptcyto, the sample was
halved and photolyzed either before or after retrotranslo-
cation was initiated by raising the temperature to 30C.
After aliquots were removed to examine photoadduct for-
mation in the total sample and in the microsome and
supernatant fractions (Figure S4), the remainder was split
into thirds and immunoprecipitated with antibodies to
Der1, Sec61a, or TRAM, a core component of the translo-
con (Johnson and van Waes, 1999). A photoadduct was
immunoprecipitated with aDer1 (Figure 6, lanes 1 and 2),
but not with aSec61a (Figure 6, lanes 5 and 6) or aTRAM
(Figure 6, lanes 9 and 10). No photoadducts were seen
in the absence of probe (Figure 6, lanes 3 and 4). Since
photolyzed ANB has a short reactive lifetime, photoad-
ducts are formed only with molecules in close proximity
to Dgpaf at the time of photolysis. Therefore, Dgpaf was
adjacent to derlin-1 but not detectably proximal to
Sec61a or TRAM.
The number of Dgpaf photocrosslinks to cytosolic pro-
teins increased over time, thereby indicating that the pho-950 Cell 129, 943–955, June 1, 2007 ª2007 Elsevier Inc.toreactiveDgpaf was transported through the retrotranslo-
cation site during the 30min incubation (Figure S4). Yet the
yield of Dgpaf-derlin-1 photoadduct was approximately
the same at 0C and 30C (Figure 6, lanes 1 and 2), which
shows that Dgpaf was adjacent to derlin-1 both before
andafter retrotranslocationwas initiated (seebelow). Since
the photoreactive probes were incorporated randomly into
the nine Lys codons of Dgpaf, not all probes in a single
Dgpaf were adjacent to retrotranslocation-site proteins at
the timeofphotolysis.Furthermore, onlya fewof thephoto-
reactive Dgpaf molecules were in the retrotranslocation
site at the time of photolysis. For these reasons, the yield
of Dgpaf-derlin-1 photoadduct was relatively low. How-
ever, the critical observation is that Dgpaf photoadducts
were formed with derlin-1, but not with Sec61a or TRAM.
DISCUSSION
The real-time continuous detection of Dgpaf-BOF retro-
translocation and its dependence on various components
provides a unique perspective on the mechanisms and
roles of individual proteins during retrotranslocation in
Figure 6. Dgpaf Photocrosslinking to Derlin-1
pDgpaf mRNA was translated in the presence of either 3ANB-Lys-
tRNALys or Lys-tRNALys as in Figure 1 and translocated into micro-
somes in vitro in the dark as indicated. Microsomes were purified
and then photolyzed either before or after a 15 min incubation at
30C. Photolyzed samples were split and immunoprecipitated with
affinity-purified antibodies aDer1, aSec61a, or aTRAM as indicated.
Dgpaf-derlin-1 photoadduct, d; Dgpaf, :; unidentified species also
seen in nonimmune IgG control, X.
mammals. This initial study revealed, among other things,
that Dgpaf-BOF retrotranslocation occurred rapidly and
was complete within minutes, required both ATP and the
proteasome, was ubiquitin independent, was p97 and
cofactor independent, and occurred at the same rate
with total cytosolic proteins, purified 26S proteasomes,
or purified PA700. In addition, the rate of Dgpaf-BOF
retrotranslocation was maximal with either the full com-
plement of lumenal proteins or with oxidized PDI, was
decreased in the absence of all soluble lumenal proteins,
was increased only slightly by purified BiP and ATP, and
was decreased in the presence of reduced PDI. We also
discovered that aDer1 rapidly blocked Dgpaf-BOF efflux,
thatDgpaf photocrosslinked to derlin-1 but not to Sec61a,
that neither aSec61a nor RNCs inhibited Dgpaf-BOF ret-
rotranslocation, and that a mutant BiP that irreversibly
closes the lumenal end of the translocon pore had no
effect on retrotranslocation. Since all experiments were
performed with intact membranes, these combined pho-
tocrosslinking and fluorescence data constitute the most
direct evidence to date that derlin-1 is located in close
proximity to the pore through which Dgpaf moves through
the ER membrane.
The fluorescence approach introduced here character-
izes retrotranslocation with unprecedented time resolu-
tion. ERAD substrate movement from the lumen to the
cytosol is detected directly and in real time, thereby allow-
ing both the kinetics and the extent of retrotranslocation to
be reproducibly quantified and compared. Since this
spectral approach is nondestructive, substrate environ-
ment can be monitored continuously. More importantly,
this approach examines substrate retrotranslocation
under native conditions. Sincemembranes andmacromo-
lecular complexes are intact throughout, the functional ef-
fects of even weak or transient interactions or assemblies
can be detected without being disrupted by the detergent
required for some analyses. Furthermore, since different
aspects of the fluorescence signal can be monitored
(e.g., intensity, anisotropy, lifetime, fluorescence reso-
nance energy transfer, and accessibility to quenchers;
Johnson, 2005), spectral changes can simultaneously
monitor both retrotranslocation and other alterations in
substrate environment and conformation (e.g., proteolysis
[Figure 3C] and association with PDI [Figure 4B]). The abil-
ity to resolve different intermediate states and interactions
of the substrate allows mechanistic questions to be ad-
dressed at a higher resolution. For example, spectroscop-
ically differentiating between Dgpaf-BOF exposure to and
degradation in the cytosol (Figure 3C) shows that re-
trotranslocation precedes substrate proteolysis, as ex-
pected, and that the actual rate of retrotranslocation is
best determined using fluorescence rather than proteoly-
sis assays.
We must emphasize that we have only characterized
the retrotranslocation of a single ERAD substrate in this
initial study, and other substrates may require other com-
ponents or pathways for retrotranslocation. For example,
certain lumenal factors appear to be involved in the retro-translocation of glycosylated ERAD substrates (Hebert
et al., 2005). But the experimental approach described
here can, in principle, be used with any soluble ERAD
substrate or derivative. The biochemical reconstitution of
samples provides great flexibility in examining the influ-
ence of specific soluble proteins or small molecules on
either side of the membrane on the rate and extent of
retrotranslocation. Not only are the samples homoge-
neous and well defined in terms of components and their
concentrations, the substrates are in a uniform envi-
ronment and conformation inside the lumen. Deleting
a wild-type protein or replacing it with a purified mutant
protein during reconstitution, as was done here, provides
the same flexibility in a mammalian system that is
achieved genetically in yeast.
Several aspects of our data were unexpected. BiP has
been shown in previous studies to be required for the ret-
rotranslocation of several substrates in yeast (Nishikawa
et al., 2005), including Dgpaf (Brodsky et al., 1999; Kabani
et al., 2003), yet it had only a small stimulatory effect on
Dgpaf retrotranslocation from mammalian microsomes
(Figure 4A). Also, although BiP can function as a cha-
perone, it appears to bind weakly, if at all, to Dgpaf
(Figure 4B). BiP’s role in retrotranslocation may therefore
be more complex than is currently appreciated. In con-
trast, only oxidized PDI was required in the lumen to obtain
maximal retrotranslocation (Figures 4A and 4C). The
mechanism by which PDI promotes retrotranslocation is
not yet understood but may involve PDI binding to the
ERAD substrate (Gillece et al., 1999; Tsai et al., 2001).
Since PDI promotes the folding of proteins that lack disul-
fide bonds and unreacted Cys (Puig and Gilbert, 1994; Cai
et al., 1994; Wilkinson and Gilbert, 2004), it was not sur-
prising that PDI bound Dgpaf (Figure 4B). However, the
lower affinity of Dgpaf for oxidized PDI than for reduced
PDI was unexpected because retrotranslocation was
faster with oxidized PDI than with reduced PDI (Fig-
ure 4C). This result suggests that tight binding of PDI to
Dgpaf inhibits retrotranslocation. It is also possible that
oxidized, but not reduced, PDI interacts with the ret-
rotranslocation machinery at the membrane and/or that
the presence of 5 mM DTT in the microsomes reduces lu-
menal disulfide bonds and slows retrotranslocation. But
since cholera toxin movement from the lumen to the cyto-
sol is promoted by reducing agents (Tsai et al., 2001), PDI
involvement in retrotranslocation is likely substrate
dependent.
The presence of p97, Npl4, and Ufd1 in the cytosol,
either by themselves or added to total cytosolic proteins,
did not stimulate Dgpaf retrotranslocation (Figure 3A).
Since these proteins facilitate the retrotranslocation of
most examined ubiquitinylated substrates (Bays and
Hampton, 2002; Tsai et al., 2002) and Dgpaf is not ubiqui-
tinylated, this result may be expected. But it shows, con-
trary to some suggestions, that p97 is not required for the
retrotranslocation of every ERAD substrate (Lee et al.,
2004; Kothe et al., 2005; Wojcik et al., 2006; Carlson
et al., 2006). Instead, PA700 is sufficient for maximalCell 129, 943–955, June 1, 2007 ª2007 Elsevier Inc. 951
Dgpaf retrotranslocation (Figures 3B and 3D). Since ATP is
also required and NEM-treated PA700 was retrotranslo-
cation defective, it seems likely that AAA ATPase compo-
nents of PA700 are involved in powering substrate move-
ment through the membrane via the chaperone-like
properties of PA700 (Strickland et al., 2000; Liu et al.,
2002). The roles of individual PA700 subunits in retrotrans-
location will be clarified by future experiments.
The membrane proteins that form the channel through
which ERAD substrates are transported from the lumen
to the cytosol have not been identified. Retrotranslocation
was initially proposed to occur via the Sec61a translocon
pore (Wiertz et al., 1996; Plemper et al., 1997; Pilon et al.,
1997; Zhou and Schekman, 1999), and some subsequent
data are consistent with this model (Gillece et al., 2000;
Schmitz et al., 2000; Lee et al., 2004; Kalies et al., 2005;
Ng et al., 2007). Other studies have proposed that der-
lin-1 and its homologs, derlin-2 and derlin-3, are located
at the site of retrotranslocation (Ye et al., 2005; Lilley
and Ploegh, 2005; Oda et al., 2006; Lilley et al., 2006).
As summarized above, we found in this study that the
rate and extent of Dgpaf-BOF retrotranslocation were
not affected by closing either end of the translocon pore.
Instead, two independent techniques—Dgpaf photocros-
slinking to derlin-1 (Figure 6) and aDer1 blockage of
Dgpaf-BOF retrotranslocation (Figure 5D)—strongly indi-
cated that derlin-1 is located at the site of retrotransloca-
tion. Our data therefore strongly suggest that derlin-1 is
a structural and/or functional component of the site of
Dgpaf retrotranslocation. Future experiments will deter-
mine whether or not more complex ERAD substrates
are retrotranslocated through different retrotranslocation
sites, molecular assemblies, and/or pathways.
Continuous monitoring of retrotranslocation revealed
that aDer1 did not block Dgpaf retrotranslocation at t0
but did block retrotranslocation after 2 min (Figure 5D).
The delay presumably resulted from aDer1 being initially
unable to bind to derlin-1 or block its function when the
antibodies were mixed with the RRMs. One possible
explanation is that aDer1 does not bind to a derlin-1 that
is already engaged with an ERAD substrate but does
bind to an unoccupied derlin-1. In this case, any Dgpaf-
BOF bound to the retrotranslocation site at 0C would
be transported normally to give the maximal initial rate of
retrotranslocation, but further retrotranslocation would
be blocked when aDer1 bound to retrotranslocation sites
following substrate release. Since Dgpaf photocrosslink-
ing to derlin-1 was the same at t0 and at t = 15 min (Fig-
ure 6), Dgpaf was positioned adjacent to derlin-1 at both
0C and 30C. These combined data suggest that Dgpaf
can be trapped at an intermediate stage of retrotransloca-
tion by varying the temperature: Dgpaf appears to be tar-
geted to a derlin-1-containing retrotranslocation site at
low temperature to form amembrane-bound intermediate
and only passes through the site when the temperature is
raised (Figure 5D; Figure 6; Figure S3). If so, the C-terminal
end of Dgpaf must move through the retrotranslocation
site in <2 min (Figure 5D). Future real-time spectroscopic952 Cell 129, 943–955, June 1, 2007 ª2007 Elsevier Inc.characterizations of retrotranslocation using various sub-
strates and the mammalian biochemical approach de-
scribed here will provide additional insights into themech-
anisms that regulate and accomplish retrotranslocation.
EXPERIMENTAL PROCEDURES
Reconstituted Rough Microsomes
Canine ER microsomes were extracted by exposure to high pH and
then reconstituted on ice with 4–5 mM Dgpaf-BOF, 2 mM ATP, and
3.5 mg/ml of total soluble lumenal proteins to form cptRRMs (Alder
et al., 2005). Alternatively, RRMs were prepared with 2 mM ATP and
either 10–20 mM BiP or 10–20 mM PDI in the presence of either 5 mM
DTT or 5 mM GSSG. For some experiments, extracted RRMs were
incubated (0C, 5–10 min) with 20 mM T37G BiP + 2 mM ATP before
Dgpaf-BOF and other lumenal proteins were added to complete the
reconstitution. Before use, RRMs were gel filtered (Sepharose CL-
2B; 50 cm 3 0.7 cm inside diameter) at 4C to remove nonencapsu-
lated proteins.
Retrotranslocation by Proteolysis
pDgpaf mRNAwas transcribed in vitro using SP6RNA polymerase and
then translated (350 ml, 26C, 60 min) in a wheat-germ cell-free extract
as before (Flanagan et al., 2003) in the presence of 150 mCi [35S]Met,
40 nMcanineSRP, 96 equivalents (Eq) of salt-washed canine ERmicro-
somes, and 210 pmol of E. coli Lys-tRNALys or 3BOF-Lys-tRNALys
(Woolhead et al., 2004). Microsomes were pelleted and resuspended
in 350 ml of buffer B (2 mM ATP, 2 mM GTP, 16 mM phosphocreatine,
16 units/ml creatine phosphokinase, and protease inhibitors in buffer A
[50 mMHEPES (pH 7.5), 40 mMKOAc, 5 mMMgCl2]) containing either
60 ml of reticulocyte lysate, 240 ml of cyto, or no lysate. Samples were
then incubated at 30C, and 100 ml aliquots were removed at the indi-
cated times for analysis by SDS-PAGE on a 10%–20% gel. 35S and
BOF fluorescence were quantified using a Bio-Rad FX imager.
Retrotranslocation by Fluorescence
A photon-counting steady-state SLM 8100 with a double-grating exci-
tationmonochromator, a single-grating emissionmonochromator, and
a 450 W xenon lamp was used for all experiments, as were 4 3 4 mm
quartz cuvettes. (The same results were obtained with 1 3 1 cm
cuvettes.) lex and lem were 490 nm and 513 nm (4 nm band pass).
A retrotranslocation sample contained 10 Eq of RRMs that were
incubated (0C, 30 min) with an excess (30 mg/ml) of aBOF in 240 ml
of buffer B; a parallel sample lacked aBOF. Because RRMs scatter
light efficiently, two additional control samples were prepared that
contained Dgpaf instead of Dgpaf-BOF. Each sample was then mixed
with cyto (to a final concentration of 0.3mg/ml; ±epoxomicin); 26S pro-
teasomes (to 20 mg/ml; ±epoxomicin); PA700/19S RP (to 40 mg/ml;
±NEM); and/or p97, Npl4, and Ufd1 (to 0.25 mM each) to form
a 300 ml final sample in buffer B. RRMs were equalized in samples
using light scattering (lex = 405 nm, lem = 420 nm, 4 nm band pass).
Retrotranslocation was initiated at t0 by transferring the sample from
ice to the SLM cell holder at 30C. Emission intensities were recorded
for 5 s at 40 s intervals. The intensities of theDgpaf control samples did
not change with time and were subtracted from the intensities of the
equivalent Dgpaf-BOF samples to yield the net emission intensities.
The aBOF-dependent intensity change (F) was given by the ratio of
the net intensities measured at each time point in the presence versus
absence of aBOF (F = F+aBOF/FaBOF). The average F values and stan-
dard error of the mean for n independent experiments are shown in
Figures 2–5.
In some experiments, RRMs were incubated (0C, 30 min) with
aSec61a (3 mg/ml) or aDer1 (3 mg/ml) prior to the addition of cytosolic
proteins to form retrotranslocation samples (Figures 5B and 5C). In
others, RNCs with an 86-residue preprolactin nascent chain were pre-
pared using truncated mRNAs and purified as before (Flanagan et al.,
2003). RNCs (10–20 nM) were then incubated (0C, 30 min) with 10 Eq
of cptRRMs and 40 nM SRP in buffer A + 2mMGTP before mixing with
cytosolic proteins in buffer B to initiate retrotranslocation.
PDI Binding to Dgpaf-BOF
Dgpaf-BOF was titrated with BiP or PDI at 4C in buffer A, and associ-
ation was detected by an increase in anisotropy (r, measured as
described previously; Johnson et al., 1982). Procedures were as
described (Flanagan et al., 2003), except that a separate sample was
prepared for each PDI or BiP concentration. Protein adsorption to
cuvette walls was prevented by coating them as described (Ye et al.,
1991).
Photocrosslinking
pDgpaf mRNA was translated as above (350 ml, 26C, 60 min) in the
dark, except that samples contained either 210 pmol of Lys-tRNALys
or 420 pmol of 3ANB-Lys-tRNALys. After microsomes were purified
by sedimentation and mixed with cptcyto, aliquots (50 ml) were photo-
lyzed either before (0 min sample) or after a 15 min incubation at 30C.
After pelleting, photoadducts were immunoprecipitated with aSec61a,
aTRAM, or aDer1 as before (McCormick et al., 2003), except that
aDer1 was bound in 140 mM NaCl, 10 mM Tris-HCl (pH 7.6), 1%
(v/v) Triton X-100.
Supplemental Data
Supplemental Data include Supplemental Results, Supplemental Ex-
perimental Procedures, Supplemental References, and four figures
and can be found with this article online at http://www.cell.com/cgi/
content/full/129/5/943/DC1/.
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